商业事件2026-10-16 22:09

Snabbit Spent ₹16 To Earn Every Rupee In Operating Revenue In FY26

Snabbit Spent ₹16 To Earn Every Rupee In Operating Revenue In FY26

Amid intense competition in the quick home services market, Snabbit incurred a net loss of ₹167.8 Cr in the financial…

Amid intense competition in the quick home services market, Snabbit incurred a net loss of ₹167.8 Cr in the financial…
海外
商业观察Inc42
商业事件2026-10-16 21:59

Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients

Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients

OMass Therapeutics, a UK BioTech company developing small molecule therapeutics against highly validated target ecosystems, announced an oversubscribed €275 million (£230 million) Series C round. The round was co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with additional participation from Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences. Each […] The post Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients appeared first on EU-Startups.

OMass Therapeutics, a UK BioTech company developing small molecule therapeutics against highly validated target ecosystems, announced an oversubscribed €275 million (£230 million) Series C round. The round was co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with additional participation from Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences. Each […] The post Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients appeared first on EU-Startups.
海外€275 m
商业观察EU-Startups
商业事件2026-10-16 21:18

OPINION: How founders can stop wasting time on fundraising

OPINION: How founders can stop wasting time on fundraising

Any founder who has raised money knows what investor due diligence feels like from the receiving end. The questions about the model, the customer contracts, the gap in your CV, the calls to people you worked with years ago. Investors do that work because they are making a long-term bet on your abilities. However, the […] The post OPINION: How founders can stop wasting time on fundraising appeared first on EU-Startups.

Any founder who has raised money knows what investor due diligence feels like from the receiving end. The questions about the model, the customer contracts, the gap in your CV, the calls to people you worked with years ago. Investors do that work because they are making a long-term bet on your abilities. However, the […] The post OPINION: How founders can stop wasting time on fundraising appeared first on EU-Startups.
海外
商业观察EU-Startups
商业事件2026-10-16 19:37

嘉立创:筹划发行H股并申请在港交所主板上市

Jialichuang: Planning to issue H shares and apply for listing on the main board of the Hong Kong Stock Exchange

嘉立创公告,公司正在筹划发行境外上市股份(H股)并申请在香港联合交易所有限公司主板挂牌上市。

36 Krypton learned that Jiali Chuang announced that the company is planning to issue overseas listed shares (H shares) and apply for listing on the Main Board of The Stock Exchange of Hong Kong Limited.
国内香港
商业观察36Kr
商业事件2026-10-16 19:32

卫星化学:前三季度净利润90.59亿元,同比增长141.24%

Satellite chemistry: net profit of 9.059 billion yuan in the first three quarters, up 141.24% year-on-year

卫星化学公告,2026年第三季度营业收入157亿元,同比增长38.81%;归属于上市公司股东的净利润28.32亿元,同比增长180.03%。2026年前三季度营业收入464.14亿元,同比增长33.49%;归属于上市公司股东的净利润90.59亿元,同比增长141.24%。

Satellite Chemistry announced that operating income in the third quarter of 2026 was 15.7 billion yuan, an increase of 38.81% year-on-year; net profit attributable to shareholders of listed companies was 2.832 billion yuan, an increase of 180.03% year-on-year. Operating income in the first three quarters of 2026 was 46.414 billion yuan, an increase of 33.49% year-on-year; net profit attributable to shareholders of listed companies was 9.059 billion yuan, an increase of 141.24% year-on-year.
国内90.59亿元
商业观察36Kr
商业事件2026-10-16 19:22

Urban Company Q2 Loss Widens Over 3X YoY To ₹182.5 Cr, Revenue Up 41%

Urban Company Q2 Loss Widens Over 3X YoY To ₹182.5 Cr, Revenue Up 41%

Consumer service brand Urban Company’s net loss has widened 208% YoY to ₹182.5 Cr in the Q2 FY27 from ₹59.3…

Consumer service brand Urban Company’s net loss has widened 208% YoY to ₹182.5 Cr in the Q2 FY27 from ₹59.3…
海外
商业观察Inc42
商业事件2026-10-16 19:20

马斯克的飞行汽车来了!特斯拉和SpaceX合体更进一步?

Musk's flying car is here! Tesla and SpaceX go one step further?

头条精选脑机接口“卡脖子”芯片,这家海南公司造出来了头条精选AI读遍了互联网,却还没学会老师傅的手艺:Physical AI缺的数据在人手里头条精选400亿!53岁宁波老板带着“非洲手机之王”,敲钟港交所头条精选非洲第一的“电子钱包”,要IPO了头条精选

The headline selection brain-computer interface "card neck" chip, this Hainan company has created a headline selection AI to read the Internet, but has not yet learned the skills of the teacher: Physical AI lack of data in the hands of the headline selection 40 billion! 53-year-old Ningbo boss with "the king of African mobile phones", ringing the bell Hong Kong Stock Exchange headline selection Africa's first "electronic wallet", to IPO the headline selection
国内浙江
商业观察创业邦
商业事件2026-10-16 19:18

胜宏科技:董事长提议1.5亿元—3亿元回购公司股份

Sheng Hong Technology: Chairman proposes 150 million yuan to 300 million yuan to repurchase the company's shares

胜宏科技公告,公司实际控制人兼董事长陈涛提议1.5亿元—3亿元回购公司股份,用于员工持股计划或股权激励。

胜宏科技公告,公司实际控制人兼董事长陈涛提议1.5亿元—3亿元回购公司股份,用于员工持股计划或股权激励。
国内1.5亿元
商业观察36Kr
商业事件2026-10-16 19:13

科翔股份:前三季度净利润2.44亿元,同比扭亏

科翔股份:前三季度净利润2.44亿元,同比扭亏

科翔股份公告,2026年第三季度营业收入18.5亿元,同比增长100.9%;归属于上市公司股东的净利润3.11亿元,同比扭亏。2026年前三季度营业收入39.79亿元,同比增长45.92%;归属于上市公司股东的净利润2.44亿元,同比扭亏。

科翔股份公告,2026年第三季度营业收入18.5亿元,同比增长100.9%;归属于上市公司股东的净利润3.11亿元,同比扭亏。2026年前三季度营业收入39.79亿元,同比增长45.92%;归属于上市公司股东的净利润2.44亿元,同比扭亏。
国内2.44亿元
商业观察36Kr
商业事件2026-10-16 19:12

New treatment for inflammatory bowel disease lands Microbiotica €42 million

New treatment for inflammatory bowel disease lands Microbiotica €42 million

Microbiotica, a British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines, today announces the first close of a €42 million (£36 million) Series C financing. The financing was led by British Business Bank, with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, and Seventure Partners. All existing Series B investors […] The post New treatment for inflammatory bowel disease lands Microbiotica €42 million appeared first on EU-Startups.

Microbiotica, a British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines, today announces the first close of a €42 million (£36 million) Series C financing. The financing was led by British Business Bank, with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, and Seventure Partners. All existing Series B investors […] The post New treatment for inflammatory bowel disease lands Microbiotica €42 million appeared first on EU-Startups.
海外€42 m
商业观察EU-Startups
商业事件2026-10-16 19:06

罗博特科:董事长提议5000万元—1亿元回购公司股份

罗博特科:董事长提议5000万元—1亿元回购公司股份

罗博特科公告,公司实际控制人、董事长兼CEO戴军提议5000万元—1亿元回购公司股份,本次回购的股份拟全部予以注销并减少公司注册资本。

罗博特科公告,公司实际控制人、董事长兼CEO戴军提议5000万元—1亿元回购公司股份,本次回购的股份拟全部予以注销并减少公司注册资本。
国内5000万元
商业观察36Kr
商业事件2026-10-16 19:03

江丰电子:控股股东提议5000万元—1亿元回购公司股份

江丰电子:控股股东提议5000万元—1亿元回购公司股份

江丰电子公告,公司控股股东、实际控制人、首席技术官姚力军提议5000万元—1亿元回购公司股份,用于后续的员工持股计划或股权激励计划。

江丰电子公告,公司控股股东、实际控制人、首席技术官姚力军提议5000万元—1亿元回购公司股份,用于后续的员工持股计划或股权激励计划。
国内5000万元
商业观察36Kr
商业事件2026-10-16 18:56

豪威集团:拟2.5亿元—5亿元回购公司股份

豪威集团:拟2.5亿元—5亿元回购公司股份

豪威集团公告,拟以集中竞价交易方式回购A股股份,回购股份金额不低于2.5亿元,不高于5亿元,回购股份价格不高于120元/股,回购股份拟用于实施员工持股计划或股权激励。

豪威集团公告,拟以集中竞价交易方式回购A股股份,回购股份金额不低于2.5亿元,不高于5亿元,回购股份价格不高于120元/股,回购股份拟用于实施员工持股计划或股权激励。
国内2.5亿元
豪威集团36Kr
商业事件2026-10-16 18:45

深交所:本周共对114起证券异常交易行为采取自律监管措施

深交所:本周共对114起证券异常交易行为采取自律监管措施

据深交所,2026年10月12日至10月16日,深交所共对114起证券异常交易行为采取了自律监管措施,涉及盘中拉抬打压、虚假申报等异常交易情形;共对6起上市公司重大事项进行核查,并上报证监会1起涉嫌违法违规案件线索。

据深交所,2026年10月12日至10月16日,深交所共对114起证券异常交易行为采取了自律监管措施,涉及盘中拉抬打压、虚假申报等异常交易情形;共对6起上市公司重大事项进行核查,并上报证监会1起涉嫌违法违规案件线索。
国内
商业观察36Kr
商业事件2026-10-16 18:43

鸿富瀚:拟10.07亿元投建机器人精密金属组件生产基地项目

鸿富瀚:拟10.07亿元投建机器人精密金属组件生产基地项目

鸿富瀚公告,拟使用首次公开发行股票剩余超募资金及超募资金存储期间产生的利息、现金管理收益以及自有及自筹资金投资建设“鸿锦瀚机器人精密金属组件生产基地项目”,本项目计划投资总额为10.07亿元。

鸿富瀚公告,拟使用首次公开发行股票剩余超募资金及超募资金存储期间产生的利息、现金管理收益以及自有及自筹资金投资建设“鸿锦瀚机器人精密金属组件生产基地项目”,本项目计划投资总额为10.07亿元。
国内10.07亿元
鸿富瀚36Kr
商业事件2026-10-16 18:40

凯旺科技:拟3000万元—6000万元回购公司股份

凯旺科技:拟3000万元—6000万元回购公司股份

凯旺科技公告,拟3000万元—6000万元回购公司股份,用于股权激励或员工持股计划,本次回购股份价格不超过70元/股。

凯旺科技公告,拟3000万元—6000万元回购公司股份,用于股权激励或员工持股计划,本次回购股份价格不超过70元/股。
国内3000万元
凯旺科技36Kr
商业事件2026-10-16 18:36

东山精密港股上市获中国证监会备案

东山精密港股上市获中国证监会备案

中国证监会国际合作司发布关于苏州东山精密制造股份有限公司境外发行上市备案通知书,公司拟发行不超过234038600股境外上市普通股并在香港联合交易所上市。

中国证监会国际合作司发布关于苏州东山精密制造股份有限公司境外发行上市备案通知书,公司拟发行不超过234038600股境外上市普通股并在香港联合交易所上市。
国内江苏
商业观察36Kr
商业事件2026-10-16 18:35

瑞可达:董事长提议5000万元至1亿元回购公司股份

瑞可达:董事长提议5000万元至1亿元回购公司股份

瑞可达公告,公司董事长吴世均提议公司通过集中竞价交易方式回购部分公司股票,并在未来适宜时机用于员工持股计划、股权激励或用于转换公司发行的可转换为股票的公司债券,回购资金总额不低于5000万元,不超过1亿元。

瑞可达公告,公司董事长吴世均提议公司通过集中竞价交易方式回购部分公司股票,并在未来适宜时机用于员工持股计划、股权激励或用于转换公司发行的可转换为股票的公司债券,回购资金总额不低于5000万元,不超过1亿元。
国内5000万元
商业观察36Kr